Alzheimer disease: Epigenetics links ageing with Alzheimer disease.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed.

1. Histone Deacetylation in Alzheimer's Diseases (AD); Hope or Hype.Cell biochemistry and biophysics · 2025
   Review
2. Epigenetic Alterations in Alzheimer's Disease: Impact on Insulin Signaling and Advanced Drug Delivery Systems.Biology · 2024
   Review
3. The Potential of a Stratified Approach to Drug Repurposing in Alzheimer's Disease.Biomolecules · 2023
   Review
4. mEpigenetics · 2022
   Article
5. Degradation and inhibition of epigenetic regulatory protein BRD4 exacerbate Alzheimer's disease-related neuropathology in cell models.The Journal of biological chemistry · 2022
   Article
6. Epigenetics in Alzheimer's Disease.Frontiers in aging neuroscience · 2022
   Review
7. Recent progress in translational engineered in vitro models of the central nervous system.Brain : a journal of neurology · 2020
   Review
8. Preventive Electroacupuncture Ameliorates D-Galactose-Induced Alzheimer's Disease-Like Pathology and Memory Deficits Probably via Inhibition of GSK3Evidence-based complementary and alternative medicine : eCAM · 2020
   Article
9. Microfluidic Brain-on-a-Chip: Perspectives for Mimicking Neural System Disorders.Molecular neurobiology · 2019
   Review
10. Does SCFD1 rs10139154 Polymorphism Decrease Alzheimer's Disease Risk?Journal of molecular neuroscience : MN · 2019
    Article
11. Dementia in Down syndrome: unique insights for Alzheimer disease research.Nature reviews. Neurology · 2019
    Review

Corrections and comments

• Comment on
  Dysregulation of the epigenetic landscape of normal aging in Alzheimer's disease.2018

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as